Form 4 for ONC BeOne Medicines Ltd.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-15 · accession 0001651308-23-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-20 | 2023-06-15 | ONC | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +200.4K | 1.03M | +24% | $0 |
| D | 2023-06-20 | 2023-06-20 | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $192.44 | -1,753 | 0 | -100% | -$337.3K |
| D | 2023-06-20 | 2023-06-15 | ONC | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +760.9K | 760.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-06-15 | A | A | 200,447 | $0.00 | 1,033,432 | D | — | — | (F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. |
| 2 | Common | American Depositary Shares | 2023-06-20 | S | D | 1,753 | $192.44 | 0 | D | — | — | (F2) Each American Depositary Share represents 13 Ordinary Shares. (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.41 to $192.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. |
| 3 | Derivative | Share Option (Right to Buy) | 2023-06-15 | A | A | 760,851 | $0.00 | 760,851 | D | $16.41 · — to 2033-06-14 | 760,851 Ordinary Shares | (F8) The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. (F9) These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. |